Safety and Efficacy of MP-214 in Patients With Schizophrenia

Mise à jour : Il y a 4 ans
Référence : NCT01625000

Femme et Homme

Extrait

The objective of this study is to evaluate the efficacy, safety, and tolerability of MP-214 relative to placebo in patients with acute exacerbation of schizophrenia.


Critère d'inclusion

  • Schizophrenia

Liens